FIELD: pharmaceutics.
SUBSTANCE: invention relates to novel substituted 2H-pyrazole derivative acting as a selective inhibitor of CDK4/6. In particular, the disclosed invention is a substance of formula (I) or a pharmaceutically acceptable salt thereof, which acts as a selective inhibitor of CDK4/6.
EFFECT: disclosed is substituted 2H-pyrazole derivative.
18 cl, 4 tbl, 35 ex
Title | Year | Author | Number |
---|---|---|---|
HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS | 2019 |
|
RU2812128C2 |
SELECTIVE KINASE JAK1 INHIBITOR | 2020 |
|
RU2818002C2 |
TRICYCLIC INHIBITORS OF GYRASE | 2012 |
|
RU2626979C2 |
INDOLIN-2-ONE OR PYRROLO-PYRIDIN/PYRIMIDIN-2-ONE DERIVATIVES | 2014 |
|
RU2666532C2 |
HETEROARYL[4,3-c]PYRIMIDINE-5-AMINE DERIVATIVE, ITS PREPARATION METHOD AND ITS MEDICAL APPLICATIONS | 2018 |
|
RU2764655C2 |
PHENICOL ANTIBACTERIAL AGENTS | 2013 |
|
RU2593204C2 |
NOVEL COUMARIN DERIVATIVES WITH ANTI-TUMOUR ACTIVITY | 2007 |
|
RU2428420C2 |
BENZIMIDAZOLE DERIVATIVES | 2020 |
|
RU2803284C1 |
INHIBITOR OF EGFR AND PRODUCTION AND USE THEREOF | 2015 |
|
RU2702631C2 |
TRIAZOLO-PYRIMIDINE COMPOUNDS AND THEIR USE | 2019 |
|
RU2802866C2 |
Authors
Dates
2020-05-29—Published
2016-03-10—Filed